| Summary: | 碩士 === 國立交通大學 === 高階主管管理碩士學程 === 98 === Alone with more and more advanced medical technology, new medicines are innovatively developed. Therefore dramatic competition between generic & original drug after patent protection comes up. This study is based on SWOT method to analyze generic & patent drug of operation & market strategy in the pharmaceutical industry. This study found that multiple national pharmaceutical companies who have patent drugs have strong international advantage, marketing capability, quality of personnel, etc., but less benefits in management of operating expenses, cost control and crisis control than the domestic generic pharmaceutical companies. On the other hand, domestic generic pharmaceutical companies are not effective in upgrading quality of companies and lack of international experience. They fall into the price war in order to grab big market share. Thus, I hope this study can provide data for those companies to develop competitive strategies in the future.
|
|---|
